E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/10/2008 in the Prospect News Convertibles Daily and Prospect News Special Situations Daily.

Allscripts sets special cash dividend amount at $5.23

By Jennifer Chiou

New York, Oct. 10 - Allscripts Healthcare Solutions, Inc. announced that the special cash dividend to be paid to its stockholders on Oct. 17 will equal $5.23 per share.

As previously announced, the company will pay a special cash dividend totaling $330 million that is conditioned on its merger with Misys plc.

As of the close of business on Oct. 9 - the record date for the dividend - holders of $54.6 million of Allscripts' 3.5% convertible senior debentures had elected to convert their holdings into shares of Allscripts common stock.

On Sept. 29, the company announced it signed definitive agreements for $325 million of financing from two sources to fund a portion of the proposed merger of Misys Healthcare Systems, LLC and a subsidiary of Allscripts.

Payment of the dividend is contingent upon the merger's close under the companies' March 17, 2008 agreement.

Misys previously said it has sufficient funding commitments in place to finance the transaction.

It was previously reported that Misys will pay $330 million in cash to Allscripts in exchange for 54.5% ownership of the combined company.

Following the merger's close, Allscripts stockholders will retain the shares they currently own, and Allscripts shares will continue to trade on the Nasdaq under the symbol "MDRX."

Allscripts is a Chicago-based clinical software company. Misys is an applications software and services company located in London.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.